APA

Yang S., Hsiao L., Chiou T., Yang C., Yu Y., Liu C., Gau J., Liu J., Chen P. & Tzeng C. (20170104). Rituximab induction therapy, survival benefits, and the increasing selection of radiotherapy as the postinduction treatment in patients with primary mediastinal large B-cell lymphoma. : Journal of the Chinese Medical Association : JCMA.

Chicago

Yang Sheng-Hsiang, Hsiao Liang-Tsai, Chiou Tzeon-Jye, Yang Ching-Fen, Yu Yuan-Bin, Liu Chun-Yu, Gau Jyh-Pyng, Liu Jin-Hwang, Chen Po-Min and Tzeng Cheng-Hwai. 20170104. Rituximab induction therapy, survival benefits, and the increasing selection of radiotherapy as the postinduction treatment in patients with primary mediastinal large B-cell lymphoma. : Journal of the Chinese Medical Association : JCMA.

Harvard

Yang S., Hsiao L., Chiou T., Yang C., Yu Y., Liu C., Gau J., Liu J., Chen P. and Tzeng C. (20170104). Rituximab induction therapy, survival benefits, and the increasing selection of radiotherapy as the postinduction treatment in patients with primary mediastinal large B-cell lymphoma. : Journal of the Chinese Medical Association : JCMA.

MLA

Yang Sheng-Hsiang, Hsiao Liang-Tsai, Chiou Tzeon-Jye, Yang Ching-Fen, Yu Yuan-Bin, Liu Chun-Yu, Gau Jyh-Pyng, Liu Jin-Hwang, Chen Po-Min and Tzeng Cheng-Hwai. Rituximab induction therapy, survival benefits, and the increasing selection of radiotherapy as the postinduction treatment in patients with primary mediastinal large B-cell lymphoma. : Journal of the Chinese Medical Association : JCMA. 20170104.